This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Apr 14;357(9263):1201; author reply 1201-2.

doi: 10.1016/S0140-6736(00)04340-3.

Prostate cancer screening

P Finne, A Auvinen, U H Stenman

PMID: 11330269
DOI: 10.1016/S0140-6736(00)04340-3

Comment

Prostate cancer screening

P Finne et al. Lancet. 2001.

. 2001 Apr 14;357(9263):1201; author reply 1201-2.

doi: 10.1016/S0140-6736(00)04340-3.

Authors

P Finne, A Auvinen, U H Stenman

PMID: 11330269
DOI: 10.1016/S0140-6736(00)04340-3

No abstract available

PubMed Disclaimer

Comment on

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer.
Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Stenman UH, et al. Lancet. 1994 Dec 10;344(8937):1594-8. doi: 10.1016/s0140-6736(94)90405-7. Lancet. 1994. PMID: 7527116
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
Wolk A, Andersson SO, Mantzoros CS, Trichopoulos D, Adami HO. Wolk A, et al. Lancet. 2000 Dec 2;356(9245):1902-3. doi: 10.1016/S0140-6736(00)03266-9. Lancet. 2000. PMID: 11130391

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information